26.85DKK-2.54%Mkt Cap: 11.45B DKKP/E: 20.81Last update: 2026-06-01
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neu…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap11.45B DKK
Enterprise Value12.23B DKK
Revenue (TTM)958.30M DKK
Gross Profit578.55M DKK
Net Income (TTM)83.34M DKK
Revenue/Share2.256 DKK
Last Price26.85 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.5K
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINIS0000000040
Valuation
P/E (Trailing)20.81
P/E (Forward)16.19
PEG—
EV/EBITDA81.42
EV/Revenue12.77
P/S12.26
P/B2.04
EPS (TTM)1.30
EPS (Forward)1.70
52W Range
25.0014% of range37.90
52W High37.90 DKK
52W Low25.00 DKK
Profitability
Gross Margin62.30%
Oper. Margin9.74%
EBITDA Margin15.68%
Profit Margin8.97%
ROE9.36%
ROA4.82%
Growth
Revenue Growth14.60%
Earnings Growth21.40%
Cash Flow & Leverage
Operating CF132.62M DKK
CapEx (TTM)32.33M DKK
FCF Margin7.69%
FCF Yield0.64%
Net Debt459.28M DKK
Net Debt/EBITDA3.06
Balance Sheet
Debt/Equity0.61
Current Ratio1.21
Quick Ratio0.63
Book Value/Sh13.49 DKK
Cash/Share0.2190 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield0.39%
Payout Ratio0.00%
Ex-Div DateMar 13, 2020
Pay Date—
Analyst Consensus
Rating—
Target (Mean)33.30 DKK
Target Range29.00 DKK – 40.00 DKK
# Analysts5
Ownership
Shares Out.426.40M
Float157.55M
Insiders12.41%
Institutions78.97%
Technical
SMA 5027.05 (-0.7%)
SMA 20030.93 (-13.2%)
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)188.43K
Avg Vol (10d)139.43K
Technical Indicators
RSI (14)57.1
MACD-0.1507
MACD Signal-0.2764
MACD Hist.+0.1257
BB Upper27.62 DKK
BB Middle26.75 DKK
BB Lower25.87 DKK
BB Width6.53%
ATR (14)0.7459 DKK
Vol Ratio (20d)4.34x